Register entry
- Registered sites
- 1
- Active NDC listings
- 20
- Live patents
- 309
- Exclusivities
- 1
- Countries
- 1
- Base
- United States
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Knoa Pharmaceuticals LLCRegistrant: Knoa Pharma LLC | 4701 International Blvd W, Wilson, North Carolina (NC) 27893, United States (USA) | Finished drug manufacture | 3002960808132080875 |
Catalogue
Drug listings by form and route
2020 active NDC listings: 20 human prescription drug. By marketing category: NDA 19, ANDA 1.
| Dosage form | NDCs |
|---|---|
| tablet, film coated, extended release | 7 |
| tablet, extended release | 6 |
| patch, extended release | 5 |
| injection, solution | 2 |
| Route | NDCs |
|---|---|
| oral | 13 |
| transdermal | 5 |
| intramuscular | 2 |
| subcutaneous | 2 |
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| knoa pharma llc | 20 |
Exclusivity
Patents and exclusivities
309| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11304908 | HYSINGLA ER, OXYCONTINhydrocodone bitartrate; oxycodone hydrochloride | product | Aug 2027 |
| 11304909 | HYSINGLA ER, OXYCONTINhydrocodone bitartrate; oxycodone hydrochloride | use | Aug 2027 |
| 11964056 | OXYCONTINoxycodone hydrochloride | product | Aug 2027 |
| 12246094 | OXYCONTINoxycodone hydrochloride | product | Aug 2027 |
| 12280152 | OXYCONTINoxycodone hydrochloride | product | Aug 2027 |
| 8808741 | OXYCONTINoxycodone hydrochloride | use | Aug 2027 |
| 8894988 | OXYCONTINoxycodone hydrochloride | product | Aug 2027 |
| 9084816 | HYSINGLA ERhydrocodone bitartrate | product | Aug 2027 |
| 9095614 | HYSINGLA ERhydrocodone bitartrate | use | Aug 2027 |
| 9095615 | HYSINGLA ERhydrocodone bitartrate | product | Aug 2027 |
| 9486412 | HYSINGLA ERhydrocodone bitartrate | product | Aug 2027 |
| 9486413 | HYSINGLA ERhydrocodone bitartrate | product | Aug 2027 |
| 9492389 | HYSINGLA ER, OXYCONTINhydrocodone bitartrate; oxycodone hydrochloride | product | Aug 2027 |
| 9492390 | HYSINGLA ERhydrocodone bitartrate | use | Aug 2027 |
| 9492391 | HYSINGLA ER, OXYCONTINhydrocodone bitartrate; oxycodone hydrochloride | use | Aug 2027 |
| 9492392 | OXYCONTINoxycodone hydrochloride | product | Aug 2027 |
| 9492393 | OXYCONTINoxycodone hydrochloride | use | Aug 2027 |
| 9545380 | HYSINGLA ERhydrocodone bitartrate | use | Aug 2027 |
| 9763933 | HYSINGLA ER, OXYCONTINhydrocodone bitartrate; oxycodone hydrochloride | product | Aug 2027 |
| 9770416 | HYSINGLA ER, OXYCONTINhydrocodone bitartrate; oxycodone hydrochloride | product | Aug 2027 |
| 9775808 | OXYCONTINoxycodone hydrochloride | product | Aug 2027 |
| 9775809 | HYSINGLA ERhydrocodone bitartrate | product | Aug 2027 |
| 8894987 | OXYCONTINoxycodone hydrochloride | product | Mar 2030 |
| 8808740 | HYSINGLA ERhydrocodone bitartrate | product | Dec 2031 |
| 9572779 | HYSINGLA ERhydrocodone bitartrate | product | Dec 2031 |
| 9750703 | HYSINGLA ERhydrocodone bitartrate | product | Dec 2031 |
| 9861584 | HYSINGLA ERhydrocodone bitartrate | product | Dec 2031 |
| 9872837 | HYSINGLA ERhydrocodone bitartrate | product | Dec 2031 |
| 10111839 | ADHANSIA XRmethylphenidate hydrochloride | use | Oct 2035 |
| 10292938 | ADHANSIA XRmethylphenidate hydrochloride | product | Oct 2035 |
| 10292939 | ADHANSIA XRmethylphenidate hydrochloride | product | Oct 2035 |
| 10449159 | ADHANSIA XRmethylphenidate hydrochloride | use | Oct 2035 |
| 10500162 | ADHANSIA XRmethylphenidate hydrochloride | use | Oct 2035 |
| 10507186 | ADHANSIA XRmethylphenidate hydrochloride | product | Oct 2035 |
| 10512612 | ADHANSIA XRmethylphenidate hydrochloride | product | Oct 2035 |
| 10512613 | ADHANSIA XRmethylphenidate hydrochloride | use | Oct 2035 |
| 10568841 | ADHANSIA XRmethylphenidate hydrochloride | product | Oct 2035 |
| 10688060 | ADHANSIA XRmethylphenidate hydrochloride | product | Oct 2035 |
| 9974752 | ADHANSIA XRmethylphenidate hydrochloride | product | Oct 2035 |
| 10722473 | ADHANSIA XRmethylphenidate hydrochloride | use | Nov 2038 |
| 11857547 | ZURNAI (AUTOINJECTOR)nalmefene hydrochloride | product | Nov 2039 |
| 11865112 | ZURNAI (AUTOINJECTOR)nalmefene hydrochloride | product | Nov 2039 |
| Product | Exclusivity | Until |
|---|---|---|
| ZURNAI (AUTOINJECTOR)NALMEFENE HYDROCHLORIDE | NP New product | Aug 2027 |
Catalogue
Marketed products
20| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Butrans | buprenorphine | patch, extended release, transdermal | 59011-750NDA |
| Butrans | buprenorphine | patch, extended release, transdermal | 59011-751NDA |
| Butrans | buprenorphine | patch, extended release, transdermal | 59011-752NDA |
| Butrans | buprenorphine | patch, extended release, transdermal | 59011-757NDA |
| Butrans | buprenorphine | patch, extended release, transdermal | 59011-758NDA |
| Hysingla ER | hydrocodone bitartrate | tablet, extended release, oral | 59011-271NDA |
| Hysingla ER | hydrocodone bitartrate | tablet, extended release, oral | 59011-272NDA |
| Hysingla ER | hydrocodone bitartrate | tablet, extended release, oral | 59011-273NDA |
| Hysingla ER | hydrocodone bitartrate | tablet, extended release, oral | 59011-274NDA |
| Hysingla ER | hydrocodone bitartrate | tablet, extended release, oral | 59011-275NDA |
| Hysingla ER | hydrocodone bitartrate | tablet, extended release, oral | 59011-276NDA |
| NALMEFENE HYDROCHLORIDE | NALMEFENE HYDROCHLORIDE | injection, solution, intramuscular, intravenous, subcutaneous | 59011-960ANDA |
| OxyContin | oxycodone hydrochloride | tablet, film coated, extended release, oral | 59011-410NDA |
| OxyContin | oxycodone hydrochloride | tablet, film coated, extended release, oral | 59011-415NDA |
| OxyContin | oxycodone hydrochloride | tablet, film coated, extended release, oral | 59011-420NDA |
| OxyContin | oxycodone hydrochloride | tablet, film coated, extended release, oral | 59011-430NDA |
| OxyContin | oxycodone hydrochloride | tablet, film coated, extended release, oral | 59011-440NDA |
| OxyContin | oxycodone hydrochloride | tablet, film coated, extended release, oral | 59011-460NDA |
| OxyContin | oxycodone hydrochloride | tablet, film coated, extended release, oral | 59011-480NDA |
| Zurnai | NALMEFENE HYDROCHLORIDE | injection, solution, intramuscular, subcutaneous | 59011-962NDA |
Neighbours
Registered in the same town
4- Merck & Co., Inc.Wilson, NC
- Fresenius Kabi USA, LLCWilson, NC
- Microbac Laboratories, Inc.Wilson, NC
- Precision Stability Storage, LLCWilson, NC
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Knoa Pharma LLC FDA approved?
- Knoa Pharma LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Knoa Pharma LLC's drugs manufactured?
- The FDA register lists Wilson, NC. Registered operations: finished drug manufacture.
- What drugs does Knoa Pharma LLC make?
- 20 products are listed under Knoa Pharma LLC in the openFDA NDC Directory, most often as tablet, film coated, extended release; tablet, extended release; patch, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.